XNK Therapeutics to present at 2nd Annual Innate Killer Europe Summit in October

Posted on by

HUDDINGE, Sweden, Oct. 5, 2023 /PRNewswire/ — XNK Therapeutics AB today announced that Anna-Karin Maltais, Chief Scientific Officer, will be speaking at the 2nd Annual Innate Killer Europe Summit in London on October 18. The meeting is the second Innate Killer Europe Summit following…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.